Filing Flows

Filing Flows › Mirum Pharmaceuticals (MIRM) › Who owns the stock

Who owns Mirum Pharmaceuticals (MIRM) stock

315 funds reported Mirum Pharmaceuticals (MIRM) shares in their latest 13F filings, worth $9.1B in all. The largest holder is Frazier Life Sciences Management, L.P. ($899M). Last quarter 162 funds added to their stakes and 136 cut them.

Largest holders of MIRM (13F)Largest holders of MIRM (13F)Frazier Life Sciences Management,…$899MJupiter Topco LLC$692MJanus Henderson Group$642MBlackRock$514MFMR LLC$430MPrice T Rowe Associates$311MVanguard Portfolio Management LLC$278MVanguard Capital Management LLC$264MState Street$254MVanguard Group$205M

Largest holders (13F)

FundSharesValueChangeQuarter
Frazier Life Sciences Management, L.P.7,679,684$899Munchanged2026-06-30
Jupiter Topco LLC5,909,184$692Mbase2026-06-30
Janus Henderson Group6,945,813$642Mincrease2026-03-31
BlackRock4,390,063$514Mincrease2026-06-30
FMR LLC3,670,314$430Mincrease2026-06-30
Price T Rowe Associates2,655,607$311Mincrease2026-06-30
Vanguard Portfolio Management LLC2,377,019$278Mincrease2026-06-30
Vanguard Capital Management LLC2,254,109$264Mdecrease2026-06-30
State Street2,170,689$254Mincrease2026-06-30
Vanguard Group2,596,089$205Mincrease2025-12-31
William Blair Investment Management, LLC1,404,741$164Mincrease2026-06-30
Geode Capital Management, LLC1,393,908$163Mincrease2026-06-30
Invesco1,364,084$160Mincrease2026-06-30
Wellington Management Group LLP1,309,987$153Mdecrease2026-06-30
Eventide Asset Management, LLC1,248,389$146Mdecrease2026-06-30

Mirum Pharmaceuticals' latest quarter

Mirum Pharmaceuticals, Q3 2026: revenue $186M (+40% year over year), operating margin -32.2%, net loss $40.8M, operating cash flow −$4.3M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most MIRM stock?

By the latest 13F filings: Frazier Life Sciences Management, L.P. ($899M); Jupiter Topco LLC ($692M); Janus Henderson Group ($642M); BlackRock ($514M); FMR LLC ($430M).

What is the short interest in MIRM?

6,663,045 shares were sold short at the 2026-10-15 settlement, -4.61% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.